|
Covidien Acquires Scandius Biomedical Inc.
Surgical Devices Global Business Unit Expands Sports Surgery Platform
NORTH HAVEN, Connecticut –November 8, 2007—Covidien Ltd. (NYSE: COV, BSX:
COV), a leading global provider of healthcare products, announced today that one of its
subsidiaries has acquired Scandius Biomedical Inc., a developer of devices for sportsrelated
surgeries. Financial terms were not disclosed.
Located in Littleton, MA, Scandius Biomedical uses a network of distributors to sell
proprietary products for arthroscopic reconstruction of the Anterior Cruciate Ligament
(ACL): the Stratis® ST Femoral Fixation System and the TriTis® Tibial Fixation System.
The systems consist of instrumentation and both non-absorbable and bioabsorbable
polymer implants.
Covidien’s Medical Devices segment currently sells a range of products for sportsrelated
surgeries, including soft tissue repair devices and access products.
“The acquisition of Scandius Biomedical demonstrates our commitment to the growing
sports surgery market and enables us to further capitalize on our historic strengths in
minimally invasive surgery,” said Scott Flora, President, Surgical Devices, Covidien.
“With the combination of Scandius Biomedical products and those we have developed
internally, Covidien will be able to offer our customers innovative soft tissue repair
devices for common sports surgery procedures.”
About Covidien
Covidien is a leading global healthcare products company that creates innovative
medical solutions for better patient outcomes and delivers value through clinical
leadership and excellence. Covidien manufactures, distributes and services a diverse
range of industry-leading product lines, including Surgical Devices, Energy-based
Devices, Respiratory and Monitoring Solutions, Patient Care and Safety Products,
Imaging Solutions, Pharmaceutical Products, Medical Supplies and Retail Products.
With 2006 revenue of nearly $10 billion, Covidien has more than 43,000 employees
worldwide in 57 countries, and its products are sold in over 130 countries. Please visit
www.covidien.com to learn more about our business.
CONTACTS:
Eric Kraus
Senior Vice President
Corporate Communications
508-261-8305
eric.kraus@covidien.com
Coleman Lannum, CFA
Vice President
Investor Relations
508-452-4343
cole.lannum@covidien.com
Bruce Farmer
Director
Financial Communications
508-452-4372
bruce.farmer@covidien.com
Wayde McMillan
Director
Investor Relations
508-452-4387
wayde.mcmillan@covidien.com
|
